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ABSTRACT 
Glutathionyl-haemoglobin (Hb-SSG) is a minor form of haemoglobin characterized by the presence of a disulfide bond 
between the β-93 cysteine residue and the thiol group of glutathione. Hb-SSG is naturally present in the erythrocytes at 
levels comparable to those of glycated haemoglobin and can be measured by MALDI mass spectrometry on very small 
samples of erythrocytes from peripheral blood. Since Hb-SSG has been recognized as a sensitive biomarker of oxidative 
stress in several degenerative diseases (diabetes, hyperlipidemia, kidney disease) and in healthy workers exposed to 
glutathione-depleting toxic agents such as butadiene, we have measured for the first time the levels of Hb-SSG in two 
groups: healthy heavy cigarette smokers and overweight-obese. For both classes of subjects, the measured levels (6.4% 
± 1.7%, n = 30 for smokers; 3.0% ± 0.8%, n = 20 for overweight-obese) are in the upper 97th percentile of those meas- 
ured in the Italian general population. Levels in smokers show a small, yet statistically significant dependence on the 
level of smoking addiction (>20 cig./day vs. 20 cig./day: 7.0% ± 1.4% vs. 5.7% ± 1.1%; p < 0.05). This biomarker thus 
adds to those presently available to rationally assess the extent of biological damage caused by tobacco smoking. 
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1. Introduction 
Tobacco smoking is a long known major cause of mor- 
bidity and premature death, mainly due to cardiovascular 
disease and lung cancer. Among the toxic effects of in- 
halation of the combustion products of tobacco, a main 
one is the induction of local and systemic oxidative stress. 
This condition occurs when the excessive production of, 
or exposure to, reactive chemical substances (e.g. metal 
ions, unsaturated aldehydes, quinones) overwhelms the 
level of natural defence mechanisms, (e.g. free radical 
quenchers, antioxidant enzymes, electrophile scavengers). 
As a consequence, key enzymes can be inactivated and 
cellular functions impaired to the point that diseases such 
as atherosclerosis and cancer can be triggered [1]. 
Overweight or obesity is a common condition in the 
population of the “western” world and can lead to long- 
term health impairment and risk of myocardial infarction, 
brain stroke and other life-threatening complications [2]. *Corresponding author. 
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One condition which may hamper weight loss notwith- 
standing interventions on diet and physical exercise is 
possibly an underlying condition of systemic oxidative 
stress [3-5]. 
It has been very recently claimed that several compo- 
nents of the atherosclerotic plaque are themselves able to 
generate reactive oxygen species thus sustaining chronic 
oxidative damage to biological structures [6]. 
The reversible oxidation of the thiol function of cys- 
teine into the disulfide plays a key role as a buffer of 
oxidation. The pool of cysteine-containing natural anti- 
oxidants collectively is referred to as the glutathione me- 
taboloma scavenges noxious agents through the forma- 
tion of the respective thioethers, while the transcription 
and the activity of detoxifying enzymes are modulated 
through the action of molecular switches based on the 
dynamic formation and dissociation of conformation- 
crucial disulfide bonds in the catalytic or allosteric do- 
mains of key proteins. 
Smoking has been recognized as one of the major 
source of an enhanced oxidation of the circulating pools 
of glutathione and cysteine to the corresponding disul- 
fides. The measurement of the concentrations of thiol and 
disulfide forms of plasma and erythrocyte thiols has been 
employed to calculate the electrochemical potential as a 
synthetic bioindicator of the redox state of tissues of non- 
smokers and smoking subjects [7]. 
Mixed disulfides of soluble thiols such as glutathione 
and cysteine with proteins also contribute to the pool of 
oxidized thiols. In particular, glutathionyl haemoglobin 
(HbSSG) is the mixed disulfide generated by reaction of 
erythrocyte haemoglobin with glutathione disulfide [8] 
(Scheme 1(a)) or with the sulphinic acid derivative of 
glutathione [9] (Scheme 1(b)) to yield a disulfide bond 
between the thiol group of glutathione and that of the 
side chain of the β-93 residue of cysteine. 
This form of Hb is naturally present in erythrocytes as 
a fraction of total haemoglobin and is thus a viable can- 
didate as an innovative biomarker of cellular oxidative 
stress [10] (both in vitro; [11] and in vivo, see Table 1) 
as well as glycated Hb which is a marker of glycemic 
status. HbSSG has been measured in micro-samples of 
peripheral blood with several instrumental techniques 
among which ion-exchange chromatography [12] and 
mass spectrometry [13,14]. 
HbSSG levels have been so far measured in the control 
population and in selected patient populations in a few 
 
 
Scheme 1. Mechanisms for production of S-glutathionylated 
haemoglobin in oxidatively stressed erythrocytes. 
countries differing from one another for ethnicity of 
population, for lifestyle and for the ease of access to 
high-quality health service. A total number of subjects 
approaching one thousand have been examined. The re- 
sults of the studies published in the literature are col- 
lected in Table 1 (see references [12-23] therein). 
As a biomarker of oxidative stress, HbSSG has been 
found to increase in a number of different conditions, 
including pathological states such as uncontrolled diabe- 
tes, nephropathy, dislipidemia, Down’s syndrome and 
Friedreich’s ataxia. It has also been found that clinical 
interventions such as haemodialysis in nephropathic pa- 
tients and administration of dietary supplements in dia- 
betic and dislipemic patients are able to lower its concen- 
tration, while patients under chronic treatment with an- 
tiepileptic drugs show increased levels. HbSSG is also in- 
creased in a dose-dependent way in healthy subjects who 
are occupationally exposed to butadiene in chemical plants. 
To investigate whether HbSSG can add up to the array 
of useful biomarkers for assessing the extent of oxidative 
stress in two conditions, smoking and obesity, which are 
common in the general population, we have measured for 
the first time the levels of HbSSG in a group of selected 
heavy smokers and in one of clinically obese patients. 
2. Materials and Methods 
2.1. Investigated Subjects 
Thirty healthy (no signs of respiratory impairment) heavy 
smokers, defined as declaring to smoke >20 cig/day for 
at least 10 years, were randomly selected from the popu- 
lation of a study the main results of which were reported 
previously [24,25]. Twenty otherwise healthy subjects, 
defined as obese on then basis of their Body Mass Index 
(BMI) exceeding the cut-off value of 25 were enrolled 
from our outpatient clinic [26]. 
The main characteristics of the fifty subjects are 
shown in Table 2. Blood samples were obtained upon 
enrolment and after an informed consent were signed by 
each, as part of their routine clinical assessment. 
This study was conducted according to the Declaration 
of Helsinki guidelines for Research on Human Subjects 
and was approved by Human Ethic Committees of Fon- 
dazione IRCCS Ca’ Granda Ospedale Maggiore Poli- 
clinico (Registration number: 1370). 
2.2. Instrumentation 
HbSSG was measured by Matrix-Assisted Laser-De- 
sorption Time-of-Flight (MALDI-ToF) mass spectrome- 
try, essentially following the method of Biroccio et al. 
(2005). Measurements were performed on an Autoflex 
III (Bruker Daltonics) instrument equipped with a 355 
nm Smart Beam solid state Nd:YAG UV laser and oper- 
ated according to the manufacturer’s directions in the 
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linear positive ion mode at a calculated resolution of ap- 
proximately 5000. External calibration of the m/z scale 
was accomplished with the manufacturer’s custom pro- 
tein mixture. Automated routines for the analysis of a 
large number of samples were established with the Flex 
Control™ software. 
2.3. Measurement Techniques 
For the measurement of HbSSG a 2 mL blood sample  
 
was withdrawn (EDTA anticoagulant) and RBC were 
immediately separated by centrifugation, washed with 
isotonic NaCl solution and aliquoted in 0.1 mL portions 
of lysate which were immediately stored at −20˚C prior 
to analysis. 
The MALDI matrix was composed of an acetonitrile- 
water 1:1 mixture saturated at room temperature with 
solid sinapinic acid (approximately 10 mg/mL) which was 
freshly prepared for each measurement session.  
Table 1. Levels of glutathionyl-haemoglobin measured in the control population and in selected patient populations in differ-
ent countries. 
Cohort country Na Fb age GSSG (%) Technique details Ref. 
Normal population Jap 20 10  3.7 ± 0.3 ESI-MS  [13] Naito , 1999 
Normal population I 20 10  8 ± 1.8 MALDI-ToF age-matched [15] Piemonte, 2001 
Normal population USA 9  1.21 ± 0.14 IEX; ESI-MS  [16] Al-Abed, 2001 
Normal population I 64 34 5.1 ± 2.3 2.65 ± 1.1 MALDI-ToF  [12] Pastore, 2003 
Normal population I 7  > 5.2 MALDI-ToF 101 M, 83 F [14] Biroccio, 2005 
Normal population I 57  1.6 - 5.2 MALDI-ToF 102 M, 83 F [14] Biroccio, 2005 
Normal population I 120  <0.5 (65.2%) MALDI-ToF 103 M, 83 F [14] Biroccio, 2005 
Normal population In 30 54 ± 6.7 4.85 ± 1.12 ESI  [17] Sampathkumar, 2005
Control group In 15 49 ± 7.6 3.15±1.99 ESI  [18] Mandal, 2007 
Foresters I 76 41 ± 9 2.1 ± 1.7 MALDI-ToF  [19] Primavera, 2008 
Workers not exposed to butadiene I 41 42 ± 7 6.3 ± 2.0 MALDI-ToF  [19] Primavera, 2008 
Diabetes mellitus Jap 10  10.2 ± 0.8 ESI Basal value [20] Naito, 2000 
Diabetes mellitus Jap 10  4.1 ± 0.4 ESI After Vit. E [20] Naito, 2000 
Diabetes type 2 Jap 37 13  7.9 ± 0.5 ESI-MS  [21] Niwa, 2000 
Diabetes mellitus USA 20  2.26 ± 0.29 IEX; ESI-MS  [16] Al-Abed, 2001 
Diabetes mellitus w/o microangiopathy In 47 56 ± 6.8 8.69 ± 1.24 ESI  [17] Sampathkumar, 2005
Diabetes mellitus w/ microangiopathy In 53 57 ± 8.4 10.94 ± 0.81 ESI  [17] Sampathkumar, 2005
Hyperlipemic subjects Jap 17 11  8.1 ± 0.8 ESI  [21] Niwa, 2000 
Haemodialysis patients Jap 10  18.6 ± 0.9 ESI Pre-dialysis [13] Naito, 1999 
Haemodialysis patients Jap 10  20.8 ± 0.9 ESI Post-dialysis [13] Naito, 1999 
Hemodialysis group In 15 50.1 ± 8.5 4.69±3.19 ESI  [18] Mandal, 2007 
Peritoneal dialysis group In 15 54.2 ± 7.1 9.99±2.97 ESI  [18] Mandal, 2007 
Transplant group In 12 49.1 ± 6.8 7.63±1.81 ESI  [18] Mandal, 2007 
Heavy smokers I 30 45.5 ± 8 6.4 ± 1.7% MALDI-ToF  this study 
Obese I 20 15 49.8 ± 13.3 3.0 ± 0.7% MALDI-ToF  this study 
Chemical workers exposed to butadiene I 41 34 ± 7 7.2 ± 2.8 MALDI-ToF  [19] Primavera, 2008 
Epileptic patients (PHE-CBZ) Yu 23  2-7 IEX  [22] Niketic, 1992 
Friedreich’s ataxia I 14 9 13.9 ± 4.1 15 ± 1.5 MALDI-ToF  [15] Piemonte, 2001 
Down’s syndrome I 46 26 6.7 ± 2.7 1.47 ± 0.6 MALDI-ToF  [12] Pastore, 2003 
Carotid stenosis surgery patients I 6 59 - 83 < 0.5 MALDI-ToF No HbSSG [23] Ghilardi, 2013 
Carotid stenosis surgery patients I 3 59 - 83 0.5 - 10 MALDI-ToF Constant level [23] Ghilardi, 2013 
Carotid stenosis surgery patients I 3 59 - 83 2 - 9 MALDI-ToF Rise and fall [23] Ghilardi, 2013 
Notes. a total number of subjects investigated in the study; b number of female subjects. Abbreviations: ESI: electrospray ionization mass spectrometry; IEX: 
ion-exchange chromatography; MALDI-ToF: matrix-Assisted Laser Desorption Ionization – Time-of-Flight mass spectrometry. 
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Table 2. Main characteristics of the examined subjects. 
smokers N Age a Smoking (cig/day) a >20 cig/day 
M 15 46 (28 - 70) 24 (10 - 40) 5/15 
F 15 45 (35 - 59) 23 (20 - 40) 6/15 
total 30 45.5 ± 8 (28 - 70) 23.7 ± 6.7 (10 - 50) 11/30 
obese    Body Mass Index a 
M 5 53 (37 - 67) None 34.5 (33.0 - 37.6) 
F 15 44 (26 - 71) 3/15 current 4/15 former 32.9 (27.3 - 44.3) 
total 20 51 (26 - 71)   
a  median (min-Max). 
For sample preparation one portion of frozen separated 
RBC was thawed and a 1:100 haemolysate was prepared. 
10 microliters of the hemolysate were mixed to an equal 
volume of a matrix solution, thoroughly mixed and four 
1-microliter portions from the same mixtures were ap- 
plied each one in the centre of a different circular spot of 
a standard 384-sample ground steel target (Bruker 
MTP384 S/N 03229). Evaporation of the solvents was 
accomplished in the free air at room temperature. The 
manual preparation of one plate with approximately 250 
spots (240 sample spots and a number of protein calibra- 
tion samples) took approximately 2 hours. Sample plates 
were inserted into the mass spectrometer for analysis 
within 4 hours from preparation. 
For analysis, desorption ionization of sample spots 
was accomplished by firing the laser beam according to 
an automated routine and accumulating valid spectra 
until a suitable signal-to-noise ratio was obtained. Analy- 
sis of an individual spot took approximately 2 - 3 min. 
Unattended analysis of the whole plate containing the 
samples of this study (approx. 250 spots) took approxi- 
mately eight hours. After acquisition, MALDI spectra 
were analyzed off-site. Spectra annotation and manual 
integration was performed by a ‘blind’ operator with the 
FlexAnalysis™ software and compared to that obtained 
with the operator-independent routine. 
Analysis and integration parameters are collected in 
Table 3. Results were exported to a custom Microsoft 
Excel® worksheet for further elaboration. 
2.4. Statistical Elaboration 
All calculations, statistical elaborations and graphics 
were performed in custom Microsoft Excel® worksheets. 
Statistical significance of differences was demonstrated 
by two-tailed t-test at a significance level of 5%. 
3. Results 
3.1. Method Establishment 
Due to the large number of samples which need to be 
measured in clinically-oriented studies and to the ne- 
cessity to perform an operator-independent unbiased 
measurement, all stages of the analytical process, start- 
ing from sample preparation and deposition, laser fir- 
ing and mass spectrometer focussing, automation of 
measurement and integration were the object of an op- 
timization study and were modified with reference to 
the published method by Biroccio et al. [14]. 
3.2. Instrumental Routine Procedures. 
To implement automated spectra processing with the 
FlexControl™ software, external calibration of the m/z 
scale was accomplished at the beginning of each mea- 
surement session with the manufacturer’s custom pro- 
tein mixture and internal calibration of the measured 
haemoglobin samples was accomplished in each meas- 
ured sample by using the signals of doubly- and singly- 
protonated homozigous - and -haemoglobin (m/z 
7564.2; 7934.2; 15128.4 and 15867.5 respectively). 
3.3. Sample Preparation and Measurement 
Main modifications to the published procedure in- 
cluded using a single-layer of sinapinic acid matrix- 
sample mixture, in order (a) to achieve a faster sample 
preparation and deposition, (b) to avoid the formation 
of a “crusty” matrix lump, thus allowing to use a much 
lower laser power, which generates a lower contamina- 
tion of the ion source and results in a lower laser con- 
sumption. The best compromise was reached by using a 
total number of 2500 shots in 50-shot groups, each 
fired in a different position of the sample shot, selected 
by the automated sample plate movement routine in the 
“random walk” mode. As for mass spectrometer focu- 
sing, using a very low Post-Ionization Extraction Delay 
(PIE) time proved beneficial especially in terms of 
resolution of the peak of protonated HbSSG from near- 
by “shoulders”, thus allowing to appreciate abundances 
lower than 1%. 
3.4. Analytical Performance 
Following optimization of all parameters, analytical 
precision of each sample was calculated on the basis of 
four replicate measurements recorded on four different 
spot depositions and automatically measured within the 
same analytical run. For samples with HbSSG/HbSH  
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Table 3. Parameters for the measurement of glutathionyl haemoglobin with the automated technique in the bruker autoflex 
instrument. 
AutoXecute method 
Laser: Fuzzy control – Parent mode ON Weight 1.00 
 Use initial laser power on new laser spot Initial laser power 35% 
  Max laser power 45% 
Evaluation: Use masses from 5000 Da to 15000 Da for evaluation and processing. 
Accumulation: Fuzzy control: OFF Sum up: 2000 shots in in 100-shot steps 
 Allow only 100 satisfactory shots per raster spot 
Movement: Measure raster: spiral very small 
 Maximal allowed shot number at one raster position – Parent mode 100 
Processing: DEFAULT 
MS/MS: DEFAULT 
FlexAnalysis - Processing method 
Peak detection algorithm Centroid  
Signal to noise threshold 6  
Relative intensity threshold 0 DEFAULT 
Minimum intensity threshold 0 DEFAULT 
Maximum number of peaks 50  
Peak width 10  
Height 80% DEFAULT 
Smoothing algorithm Savitzky-Golay  
Width 5  
Cycles 3  
Baseline subtraction TopHat DEFAULT 
 
ratios in the range of 3.5% - 11.7% was usually of 
0.4% (<0.1% - 1.1%). 
3.5. Reliability of Glutathionyl-Haemoglobin  
Measurement 
Two possible causes of measurement bias were evalu- 
ated: (a) generation of HbSSG by RBC autoxidation 
after blood withdrawal, especially under conditions 
when separation of RBCs from whole blood had to be 
delayed by as long as 6 hours or strict temperature 
control at +4˚C could not be warranted over the same 
time and (b) decomposition of HbSSG following sam- 
ple storage. 
To check whether HbSSG could be generated after 
blood sampling from the investigated subjects and prior 
to analysis, new aliquots of washed and packed RBCs 
of some control subjects coming from other similar 
studies, which had yielded no detectable levels of 
HbSSG, were re-analyzed for confirmation immedi- 
ately after preparation and after being kept at ambient 
temperature for 12 - 16 hours. None of the examined 
samples showed formation of HbSSG either in the first 
or in the second analytical run, thus out-ruling its arte- 
fact formation as a consequence of sample processing 
and storage. 
To check whether HbSSG may decompose upon 
sample storage, washed and packed RBC samples with 
initial HbSSG levels between 2 and 8% coming from 
this and from other similar studies were prepared and 
re-analyzed along with the samples of the current study. 
HbSSG levels in washed and packed RBCs do not 
change significantly when samples are stored at −20 to 
−80˚C for at least six months. These results, as a whole, 
demonstrate that measurement of HbSSG in RBC 
haemolysates by MALDI-ToF mass spectrometry is 
able to reliably detect event-related changes of 0.5 to 
0.8% of absolute values. 
The MALDI mass spectra of haemoglobin samples 
obtained from subjects with no detectable (upper panel) 
and high (lower panel) levels of haemoglobin glu- 
tathionylation are shown in Figure 1. 
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The upper spectrum, with no detectable HbSSG sig- 
nal (subject not included in this study), is only shown 
to the purpose of exemplifying the detection level of 
the employed analytical technique. The subject yield- 
ing the lower spectrum exemplifies the levels measured 
in the investigated population. Analytical precision  
(SD of four replicate measurements recorded on four 
different spot depositions of the same sample and 
automatically measured within the same analytical run) 
was of 0.9% (0.1% - 4.5%) for samples with HbSSG/ 
HbSH ratios in the range of 3.5% - 11.7%. 
3.6. Glutathionyl-Haemoglobin Levels in  
Smokers 
Mean HbSSG of the entire group of the 30 investigated 
subjects is 6.2% ± 1.4% (3.5% - 9.1%), with no appar- 
ent difference between genders and no significant sta- 
tistical correlation with the declared number of ciga- 
rettes smoked in the day. However subjects who de- 
clared smoking up to 20 cig/day had statistically lower 
HbSSG levels than those smoking >20 to 40 cig/day 
(5.7% ± 1.1% vs. 7.0% ± 1.4%; p < 0.05; Figure 2). 
 
HbSSG levels showed no correlation with haemo- 
globin levels, measured either as concentration (in g/dL) 
or as haematocrit. 
3.7. Glutathionyl-Haemoglobin Levels in  
Overweight-Obese Subjects 
Mean HbSSG of the entire group of 20 investigated 
subjects is 3.0% ± 0.8% (1.9% - 4.6%), with no appar- 
ent difference between genders and no significant sta- 
tistical correlation with the BMI calculated from height 
and weight recorded at the time of first presentation to 
the outpatient clinic. HbSSG levels showed no correla- 
tion with haemoglobin levels, measured either as con- 
centration (in g/dL) or as haematocrit. 
4. Discussion and Conclusions 
To carry large studies on oxidative stress which involve 
the measurement of glutathionyl-haemoglobin in human 
red blood cells, a method that uses MALDI-ToF mass 
spectrometry is set up and the main factors of analytical 
variability are studied. By fine-tuning sample depo- 
  
 
Figure 1. MALDI-ToF mass spectra of 1:100 haemolysates of human subjects (for measurement conditions, see Experimen-
al). t
Copyright © 2013 SciRes.                                                                              IJAMSC 
F. M. RUBINO  ET  AL. 28 
 
sition on the MALDI target and ionization and detection for human transfusion is tested by measuring HbSSG on 
conditions, analytical precision reached 0.9% (0.1% - 
4.5%) for samples with HbSSG/HbSH ratios in the range 
of 3.5% - 11.7% and sensitivity allowed to detect a frac- 
tion of HbSSG as low as 0.5%. The stability of HbSSG 
in red blood cells demonstrated to be sufficiently high for 
all our study purposes. Neither generation of HbSSG by 
autoxidation of RBC content, nor its degradation oc- 
curred even in not-so-strict sample preparation and stor- 
age conditions, in order that only standard separation and 
washing of RBC was necessary. Further confirmation of 
this observation comes from a contemporary running 
study where the stability of red blood cell concentrates 
 
the day of blood donation and after 42 days of storage at 
+4˚C [27] (Carpani et al., 2011). 
To better frame within the body of existing data the 
results from our investigated population of otherwise 
healthy subjects, the literature data which have been col- 
lected in Table 1 have been used to generate the histo- 
gram of Figure 3. Bars show the variability (min-Max) 
of the levels of HbSSG measured for different examined 
subpopulations (healthy or control groups of clinical stu- 
dies; subjects with different conditions or diseases), in- 
cluding those of this study. 
The levels measured in our study of otherwise healthy 
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Figure 2. Levels of glutathionyl haemoglobin in smoking subjects with different self-assessed mean daily cigarette consump-
tion. 
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Figure 3. Comparison of HbSSG levels measured in the literature studies (interval as determined by the reported results o
Table 1). The Country where the studies were performed are reported in the horizontal axis. 
f 
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groups of heavy smokers and of obese subjects are best 
ompared with those measured in the general Italian 
Wesseling and E. F. M. Wouters, “Systemic Effects of 
Smoking,” Chest, Vol. 1c
population by Biroccio et al. [14]. The mean values 
measured in our subjects place in the upper 3% of the 
investigated group (two-thirds of the population <0.5%; 
10th - 90th percentile of the remaining 1.6% - 5.2%). It is 
also apparent that the values measured in the Italian 
population are much lower than those reported as be-
longing to the “control groups” of the several studies 
performed in Indian and Far-Eastern populations. 
The values measured are also lower than those meas-
ured in dialyzed (5% - 20%; weighted mean 11.4%) [13, 
18] and diabetic (5% - 11%; weighted mean 8.3%) [16, 
17,20] subjects and, for the group of smokers, approxi- 
mately in the same range (7.2% ± 2.8%) of healthy sub- 
jects who are occupationally exposed to butadiene in 
chemical plants at airborne concentrations in the range 
0.1 - 200 μg/m3 [19]. 
To the best of our knowledge, this is the first study 
measuring HbSSG in a group of otherwise healthy sub- 
jects such as heavy smokers and obese, showing that 
these subjects have higher levels than those reported by 
others in a healthy population [14]. In particular, the ef- 
fect of heavy tobacco smoking in generating systemic 
oxidative stress as measured by glutathionyl haemoglo- 
bin is similar to that of a health-threatening degenerative 
disease such as diabetes and only two-fold less than that 
experienced by kidney patients undergoing life-saving 
haemo- or peritoneal dialysis. Glutathionyl-haemoglobin 
thus shows the effect of oxidative stress associated to 
tobacco smoking, and it is likely that this innovative 
biomarker may be useful to assess the extent of damage 
caused by the harmful effects of tobacco addiction and to 
monitor the health improvement associated to smoke 
cessation interventions. As for the effect on oxidative 
stress of overweight and treatment-refractory obesity, a 
low yet fairly constant level of HbSSG may strengthen 
the hypothesis that atherosclerotic plaque is itself a pro-
ducer of diffusible oxidant species [6] which are able to 
cross the erythrocyte membrane and oxidize the red 
blood cell thiolome [28], thus causing the production of 
disulfide and mixed disulfide species. 
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